231 related articles for article (PubMed ID: 17272680)
21. New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines.
Read P; Costelloe S; Mullen J; O'Shea S; Lyons F; Hay P; Welch J; Larbalestier N; Taylor G; de Ruiter A
HIV Med; 2008 Aug; 9(7):448-51. PubMed ID: 18840150
[TBL] [Abstract][Full Text] [Related]
22. Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania.
Paraschiv S; Otelea D; Baicus C; Tinischi M; Costache M; Neaga E
Int J Infect Dis; 2009 Jan; 13(1):81-9. PubMed ID: 18632295
[TBL] [Abstract][Full Text] [Related]
23. Estimating HIV evolutionary pathways and the genetic barrier to drug resistance.
Beerenwinkel N; Däumer M; Sing T; Rahnenfuhrer J; Lengauer T; Selbig J; Hoffmann D; Kaiser R
J Infect Dis; 2005 Jun; 191(11):1953-60. PubMed ID: 15871130
[TBL] [Abstract][Full Text] [Related]
24. Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure.
Lwembe R; Ochieng W; Panikulam A; Mongoina CO; Palakudy T; Koizumi Y; Kageyama S; Yamamoto N; Shioda T; Musoke R; Owens M; Songok EM; Okoth FA; Ichimura H
J Med Virol; 2007 Jul; 79(7):865-72. PubMed ID: 17516531
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.
Ghosn J; Chaix ML; Delaugerre C
AIDS Rev; 2009; 11(3):165-73. PubMed ID: 19654858
[TBL] [Abstract][Full Text] [Related]
26. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
[TBL] [Abstract][Full Text] [Related]
27. Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir.
Vergani B; Cicero ML; Vigano' O; Sirianni F; Ferramosca S; Vitiello P; Di Vincenzo P; Pia De Pasquale M; Galli M; Rusconi S
J Clin Virol; 2008 Feb; 41(2):154-9. PubMed ID: 18024202
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
29. Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China.
Zhang X; Li S; Li X; Li X; Xu J; Li D; Ruan Y; Xing H; Zhang X; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S59-65. PubMed ID: 18172393
[TBL] [Abstract][Full Text] [Related]
30. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.
Yerly S; von Wyl V; Ledergerber B; Böni J; Schüpbach J; Bürgisser P; Klimkait T; Rickenbach M; Kaiser L; Günthard HF; Perrin L;
AIDS; 2007 Oct; 21(16):2223-9. PubMed ID: 18090050
[TBL] [Abstract][Full Text] [Related]
31. Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
Derache A; Maiga AI; Traore O; Akonde A; Cisse M; Jarrousse B; Koita V; Diarra B; Carcelain G; Barin F; Pizzocolo C; Pizarro L; Katlama C; Calvez V; Marcelin AG
J Antimicrob Chemother; 2008 Sep; 62(3):456-63. PubMed ID: 18556706
[TBL] [Abstract][Full Text] [Related]
32. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
33. A combined empirical and mechanistic codon model.
Doron-Faigenboim A; Pupko T
Mol Biol Evol; 2007 Feb; 24(2):388-97. PubMed ID: 17110464
[TBL] [Abstract][Full Text] [Related]
34. Recombination in HIV and the evolution of drug resistance: for better or for worse?
Bretscher MT; Althaus CL; Müller V; Bonhoeffer S
Bioessays; 2004 Feb; 26(2):180-8. PubMed ID: 14745836
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine.
Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Saekang N; Pairoj W; Chantratita W
J Clin Virol; 2008 Apr; 41(4):310-3. PubMed ID: 18316243
[TBL] [Abstract][Full Text] [Related]
36. Towards realistic codon models: among site variability and dependency of synonymous and non-synonymous rates.
Mayrose I; Doron-Faigenboim A; Bacharach E; Pupko T
Bioinformatics; 2007 Jul; 23(13):i319-27. PubMed ID: 17646313
[TBL] [Abstract][Full Text] [Related]
37. Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
Bergroth T; Ekici H; Gisslén M; Loes SK; Goh LE; Freedman A; Lampe F; Johnson MA; Sönnerborg A
J Med Virol; 2009 Jan; 81(1):1-8. PubMed ID: 19031460
[TBL] [Abstract][Full Text] [Related]
38. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
[TBL] [Abstract][Full Text] [Related]
39. Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.
Westreich D; Eron J; Behets F; Horst Cv; Van Rie A
J Infect Dis; 2007 Mar; 195(6):837-46. PubMed ID: 17299714
[TBL] [Abstract][Full Text] [Related]
40. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
